{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:31:16Z","timestamp":1768815076130,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10620-017-4890-6","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T03:32:03Z","timestamp":1519011123000},"page":"1011-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Christopher J.","family":"Kiely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joya","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon W.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"4890_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0140-6736(65)91523-0","volume":"1","author":"AM Connell","year":"1965","unstructured":"Connell AM, Lennard-Jones JE, Misiewicz JJ, Baron JH, Jones FA. Comparison of acetarsol and prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis. Lancet. 1965;1:238.","journal-title":"Lancet"},{"key":"4890_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2036.1989.tb00247.x","volume":"3","author":"A Forbes","year":"1989","unstructured":"Forbes A, Britton TC, House IM, Gazzard BG. Safety and efficacy of acetarsol suppositories in unresponsive proctitis. Aliment Pharmacol Ther. 1989;3:553\u2013556.","journal-title":"Aliment Pharmacol Ther"},{"key":"4890_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1258\/0956462991913943","volume":"10","author":"MY Chen","year":"1999","unstructured":"Chen MY, Smith NA, Fox EF, Bingham JS, Barlow D. Acetarsol pessaries in the treatment of metronidazole resistant trichomonas vaginalis. Int J STD AIDS. 1999;10:277\u2013280.","journal-title":"Int J STD AIDS"},{"key":"4890_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3109\/00365529108998621","volume":"26","author":"E Langholz","year":"1991","unstructured":"Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in copenhagen county from 1962 to 1987. Scand J Gastroenterol. 1991;26:1247\u20131256.","journal-title":"Scand J Gastroenterol"},{"key":"4890_CR5","doi-asserted-by":"publisher","first-page":"71S","DOI":"10.1007\/BF01312468","volume":"32","author":"CN Williams","year":"1987","unstructured":"Williams CN, Haber G, Aquino JA. Double-blind, placebo-controlled evaluation of 5-asa suppositories in active distal proctitis and measurement of extent of spread using 99mtc-labeled 5-asa suppositories. Dig Dis Sci. 1987;32:71S\u201375S.","journal-title":"Dig Dis Sci"},{"key":"4890_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF00298473","volume":"5","author":"M Campieri","year":"1990","unstructured":"Campieri M, Gionchetti P, Belluzzi A, et al. Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial. Int J Colorectal Dis. 1990;5:79\u201381.","journal-title":"Int J Colorectal Dis"},{"key":"4890_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/gut.52.7.998","volume":"52","author":"CS Probert","year":"2003","unstructured":"Probert CS, Hearing SD, Schreiber S, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut. 2003;52:998\u20131002.","journal-title":"Gut"},{"key":"4890_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2036.2003.01686.x","volume":"18","author":"JM Gornet","year":"2003","unstructured":"Gornet JM, Couve S, Hassani Z, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study. Aliment Pharmacol Ther. 2003;18:175\u2013181.","journal-title":"Aliment Pharmacol Ther"},{"key":"4890_CR9","unstructured":"R Core Team. R: a language and environment for statistical computing, 2016. Available at: https:\/\/www.r-project.org\/ . Accessed 26 October 2017."},{"key":"4890_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1634\/theoncologist.6-suppl_2-1","volume":"6","author":"KH Antman","year":"2001","unstructured":"Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist. 2001;6:1\u20132.","journal-title":"Oncologist"},{"key":"4890_CR11","unstructured":"World Health Organisation. Arsenic, 2016. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs372\/en\/ . Accessed 14 June 2017."},{"key":"4890_CR12","doi-asserted-by":"crossref","unstructured":"Lewis AS. Organic versus inorganic arsenic in herbal kelp supplements. Environ Health Perspect 2007;115:A575; author reply A576\u2013577.","DOI":"10.1289\/ehp.10472"},{"key":"4890_CR13","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1097\/MJT.0b013e318245697f","volume":"21","author":"KA Nanagas","year":"2014","unstructured":"Nanagas KA, Tormoehlen LM. Extremely high urine arsenic level after remote seafood ingestion. Am J Ther. 2014;21:e75\u2013e77.","journal-title":"Am J Ther"},{"key":"4890_CR14","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1021\/es035440f","volume":"38","author":"P Andrewes","year":"2004","unstructured":"Andrewes P, Demarini DM, Funasaka K, et al. Do arsenosugars pose a risk to human health? the comparative toxicities of a trivalent and pentavalent arsenosugar. Environ Sci Technol. 2004;38:4140\u20134148.","journal-title":"Environ Sci Technol"},{"key":"4890_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/toxsci\/kfr184","volume":"123","author":"MF Hughes","year":"2011","unstructured":"Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123:305\u2013332.","journal-title":"Toxicol Sci"},{"key":"4890_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/1940-6207.CAPR-14-0251","volume":"8","author":"C Michailidi","year":"2015","unstructured":"Michailidi C, Hayashi M, Datta S, et al. Involvement of epigenetics and emt-related mirna in arsenic-induced neoplastic transformation and their potential clinical use. Cancer Prev Res (Phila). 2015;8:208\u2013221.","journal-title":"Cancer Prev Res (Phila)"},{"key":"4890_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.scitotenv.2013.11.092","volume":"472","author":"E Sturchio","year":"2014","unstructured":"Sturchio E, Colombo T, Boccia P, et al. Arsenic exposure triggers a shift in microrna expression. Sci Total Environ. 2014;472:672\u2013680.","journal-title":"Sci Total Environ"},{"key":"4890_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tox.2017.01.006","volume":"378","author":"N Banerjee","year":"2017","unstructured":"Banerjee N, Bandyopadhyay AK, Dutta S, et al. Increased microrna 21 expression contributes to arsenic induced skin lesions, skin cancers and respiratory distress in chronically exposed individuals. Toxicology. 2017;378:10\u201316.","journal-title":"Toxicology"},{"key":"4890_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/gut.34.5.676","volume":"34","author":"RD Pullan","year":"1993","unstructured":"Pullan RD, Ganesh S, Mani V, et al. Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Gut. 1993;34:676\u2013679.","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4890-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T04:21:29Z","timestamp":1570767689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4890-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"21 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was conducted with the approval of the Human Research and Ethics Committee of Cambridge University Hospitals NHS Foundation Trust.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}